α-Tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation-induced gastrointestinal injury in mice

Experimental Hematology

Volumn 40, Issue 5, 2012, Pages 407-417

  Singh, Vijay K ^a,b   Wise, Stephen Y ^a   Singh, Pankaj K ^a   Ducey, Elizabeth J ^a   Fatanmi, Oluseyi O ^a   Seed, Thomas M ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c Tech Micro Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; PLERIXAFOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CELL TRANSFER; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; JEJUNUM; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; STEM CELL MOBILIZATION; SURVIVAL;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; BLOOD CELLS; GAMMA RAYS; GASTROINTESTINAL DISEASES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROCYCLIC COMPOUNDS; INTESTINAL MUCOSA; JEJUNUM; LEUKOCYTES, MONONUCLEAR; MALE; MICE; RADIATION CHIMERA; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RECOMBINANT PROTEINS;

MUS;

EID: 84859724011     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.005     Document Type: Article

References (42)

1. Gourmelon P., Benderitter M., Bertho J.M., Huet C., Gorin N.C., De Revel P. European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal. Health Phys 2010, 98:825-832.
2. Fliedner T.M., Chao N.J., Bader J.L., et al. Stem cells, multiorgan failure in radiation emergency medical preparedness: a US/European Consultation Workshop. Stem Cells 2009, 27:1205-1211.
3. Gorin N.C., Fliedner T.M., Gourmelon P., et al. Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol 2006, 85:671-679.
4. Grdina D.J., Murley J.S., Kataoka Y. Radioprotectants: current status and new directions. Oncology 2002, 63(suppl 2):2-10.
5. Seed T.M. Radiation protectants: current status and future prospects. Health Phys 2005, 89:531-545.
6. Waddick K.G., Song C.W., Souza L., Uckun F.M. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. Blood 1991, 77:2364-2371.
7. Whitnall M.H., Elliott T.B., Landauer M.R., et al. In vivo protection against gamma-irradiation with 5-androstenediol. Exp Biol Med (Maywood) 2001, 226:625-627.
8. Weiss J.F., Landauer M.R. Radioprotection by antioxidants. Ann N Y Acad Sci 2000, 899:44-60.
9. Weiss J.F., Landauer M.R. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003, 189:1-20.
10. Weiss J.F., Landauer M.R. History and development of radiation-protective agents. Int J Radiat Biol 2009, 85:539-573.
11. Mettler F.A., Voelz G.L. Major radiation exposure-what to expect and how to respond. N Engl J Med 2002, 346:1554-1561.
12. Dumont F., Le Roux A., Bischoff P. Radiation countermeasure agents: an update. Expert Opin Ther Pat 2010, 20:73-101.
13. Bertho J.M., Prat M., Frick J., et al. Application of autologous hematopoietic cell therapy to a nonhuman primate model of heterogeneous high-dose irradiation. Radiat Res 2005, 163:557-570.
14. BitMansour A., Burns S.M., Traver D., et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood 2002, 100:4660-4667.
15. Arber C., BitMansour A., Sparer T.E., et al. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood 2003, 102:421-428.
16. Na Nakorn T., Traver D., Weissman I.L., Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 2002, 109:1579-1585.
17. BitMansour A., Cao T., Chao S., Shashidhar S., Brown J.M.Y. Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. Blood 2008, 105:3535-3537.
18. Arber C., Bitmansour A., Shashidhar S., Wang S., Tseng B., Brown J.M. Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. J Infect Dis 2005, 192:1666-1671.
19. Singh V.K., Singh P.K., Wise S.Y., Seed T.M. Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approaches. Int Immunopharmacol 2011, 11:839-844.
20. Singh V.K., Brown D.S., Kao T.C. Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol 2009, 9:1423-1430.
21. Singh P.K., Wise S.Y., Ducey E.J., Brown D.S., Singh V.K. Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine 2011, 56:411-421.
22. Singh V.K., Brown D.S., Kao T.C. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int J Radiat Biol 2010, 86:12-21.
23. Singh V.K., Parekh V.I., Brown D.S., Kao T.C., Mog S.R. Tocopherol succinate: modulation of antioxidant enzymes and oncogene expression, and hematopoietic recovery. Int J Radiat Oncol Biol Phys 2011, 79:571-578.
24. Singh V.K., Brown D.S., Kao T.C., Seed T.M. Preclinical development of a bridging therapy for radiation casualties. Exp Hematol 2010, 38:61-70.
25. Singh V.K., Ducey E.J., Fatanmi O.O., et al. CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure. Radiat Res 2011 Dec 16, [Epub ahead of print].
26. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005, 201:1307-1318.
27. Mehrotra S., Mishra K.P., Maurya R., Srimal R.C., Singh V.K. Immunomodulation by ethanolic extract of Boerhaavia diffusa roots. Int Immunopharmacol 2002, 2:987-996.
28. Withers H.R., Elkind M.M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1970, 17:261-267.
29. Herodin F., Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol 2005, 33:1071-1080.
30. Dainiak N., Waselenko J.K., Armitage J.O., MacVittie T.J., Farese A.M. The hematologist and radiation casualties. Hematol Am Soc Hematol Educ Program 2003, 473-496.
31. Weaver C.H., Schulman K.A., Buckner C.D. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Bone Marrow Transplant 2001, 27(suppl 2):S23-S29.
32. Schuening F.G., Storb R., Goehle S., et al. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 1989, 74:1308-1313.
33. Khoury H., Adkins D., Brown R., et al. Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2000, 25:1197-1201.
34. Singh V.K., Shafran R.L., Inal C.E., Jackson W.E., Whitnall M.H. Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacol Immunotoxicol 2005, 27:521-534.
35. Singh V.K., Jacobsen K.O., Grace M.B., et al. Administration of 5-androstenediol to mice: pharmacokinetics and gene expression. Exp Mol Pathol 2008, 84:178-188.
36. Singh V.K., Grace M.B., Parekh V.I., Whitnall M.H., Landauer M.H. Effects of genistein administration on cytokine induction in whole-body gamma irradiated mice. Int Immunopharmacol 2009, 9:1401-1410.
37. Singh VK, Krivokrysenko V, Shakhov A, et al. Cytokines as biomarkers for radiation countermeasures. 54th Annual Meeting of the Radiation Research Society, Boston, MA, 2008.
38. Singh VK, Brown DS, Fatanmi OO, et al. Myeloid progenitor cells as an effective treatment for acute radiation syndrome. 55th Annual Meeting of the Radiation Research Society, Savannah, GA, 2009.
39. Singh P.K., Wise S.Y., Ducey E.J., Fatanmi O.O., Elliott T.B., Singh V.K. Tocopherol succinate protects mice against radiation-induced gastrointestinal injury. Radiat Res 2011 Oct 20, [Epub ahead of print].
40. Flomenberg N., Devine S.M., Dipersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005, 106:1867-1874.
41. Pulliam A.C., Hobson M.J., Ciccone S.L., et al. AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice. Exp Hematol 2008, 36:1084-1090.
42. Ramirez P., Rettig M.P., Uy G.L., et al. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood 2009, 114:1340-1343.